Cargando…

p53: updates on mechanisms, biology and therapy (II)

Detalles Bibliográficos
Autores principales:	Lane, David P, Verma, Chandra S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734137/ https://www.ncbi.nlm.nih.gov/pubmed/31222348 http://dx.doi.org/10.1093/jmcb/mjz018

Ejemplares similares

p53: updates on mechanisms, biology and therapy (I)
por: Lane, David P, et al.
Publicado: (2019)

Updates on p53: modulation of p53 degradation as a therapeutic approach
por: Dey, A, et al.
Publicado: (2008)

Long range recognition and selection in IDPs: the interactions of the C-terminus of p53
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2016)

The p53 inducing drug dosage may determine quiescence or senescence
por: Lane, David P., et al.
Publicado: (2010)

Can Glycosylation Mask the Detection of MHC Expressing p53 Peptides by T Cell Receptors?
por: Nguyen, Thanh Binh, et al.
Publicado: (2021)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

Modulation of p53 binding to MDM2: computational studies reveal important roles of Tyr100
por: Dastidar, Shubhra Ghosh, et al.
Publicado: (2009)

Mapping the Structural and Dynamical Features of Multiple p53 DNA Binding Domains: Insights into Loop 1 Intrinsic Dynamics
por: Lukman, Suryani, et al.
Publicado: (2013)

Targeting mutant p53 for cancer therapy
por: Oren, Moshe, et al.
Publicado: (2016)

Differences in the transactivation domains of p53 family members: a computational study
por: Mavinahalli, Jagadeesh N, et al.
Publicado: (2010)

Roles of computational modelling in understanding p53 structure, biology, and its therapeutic targeting
por: Tan, Yaw Sing, et al.
Publicado: (2019)

Characterizing the conformational landscape of MDM2-binding p53 peptides using Molecular Dynamics simulations
por: Yadahalli, Shilpa, et al.
Publicado: (2017)

Understanding p53 functions through p53 antibodies
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

Corrigendum to ‘Understanding p53 functions through p53 antibodies’
por: Sabapathy, Kanaga, et al.
Publicado: (2019)

Δ113p53/Δ133p53: survival and integrity
por: Chen, Jun, et al.
Publicado: (2015)

Role of the N-terminal lid in regulating the interaction of phosphorylated MDMX with p53
por: Chan, Jane Vin, et al.
Publicado: (2017)

p53 Signaling in Cancers
por: Issaeva, Natalia
Publicado: (2019)

Alchemix, p53 and topoisomerase
por: Grand, Roger J, et al.
Publicado: (2015)

Recent Advances in p53
por: D’Orazi, Gabriella
Publicado: (2021)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

p53: out of Africa
por: Lane, David
Publicado: (2016)

Genetic modifiers of p53: opportunities for breast cancer therapies
por: Majhi, Prabin Dhangada, et al.
Publicado: (2023)

Functional characterization of p53 pathway components in the ancient metazoan Trichoplax adhaerens
por: Siau, Jia Wei, et al.
Publicado: (2016)

p53 and aging: role of p66Shc
por: Migliaccio, Enrica, et al.
Publicado: (2013)

Regulation of p53 by Helicobacter pylori
por: Zaika, Alexander, et al.
Publicado: (2012)

Simplify p53: just an activator
por: Engeland, Kurt
Publicado: (2014)

p53-induced autophagy and senescence
por: Sui, Xinbing, et al.
Publicado: (2015)

Chromatin dysregulation by mutant p53
por: Pfister, Neil T., et al.
Publicado: (2016)

The Role of p53 Family in Cancer
por: Zawacka-Pankau, Joanna E.
Publicado: (2022)

P53 levels govern the choice between senescence and quiescence
por: Meek, David W.
Publicado: (2010)

Activation of p53: How phosphorylated Ser15 triggers sequential phosphorylation of p53 at Thr18 by CK1δ
por: Nicolaou, Sonia T., et al.
Publicado: (2022)

Peripheral Nerve Regeneration: Mechanism, Cell Biology, and Therapies
por: Jia, Xiaofeng, et al.
Publicado: (2014)

p53: Pro-aging or pro-longevity?
por: de Keizer*, Peter L.J., et al.
Publicado: (2010)

p53 further extends its reach
por: Zirngibl, Katharina, et al.
Publicado: (2013)

p53 as a target in myeloproliferative neoplasms
por: Lu, Min, et al.
Publicado: (2012)

P53 in lung vascular barrier dysfunction
por: Barabutis, Nektarios
Publicado: (2020)

Understanding and Therapeutic Targeting of the p53 Network
por: Bacher, Susanne, et al.
Publicado: (2023)

Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket
por: Pradhan, Mohan R, et al.
Publicado: (2019)

Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
por: Kong, Li Ren, et al.
Publicado: (2020)

Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer
por: Kim, Michael Paul, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pcck32sp26t20nqrae61ri0ij9